Bio Preventive Medicine Corp. (TPEX:6810)
Taiwan · Delayed Price · Currency is TWD 29.15
-0.35 (-1.19%)
Jul 16, 2025, 1:58 PM CST
Bio Preventive Medicine Market Cap
Bio Preventive Medicine has a market cap or net worth of 1.47 billion as of July 16, 2025. Its market cap has increased by 15.81% in one year.
Market Cap
1.47B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
29.15
Market Cap Chart
Since August 30, 2021, Bio Preventive Medicine's market cap has increased from 711.01M to 1.47B, an increase of 106.21%. That is a compound annual growth rate of 20.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 1.46B | -1.67% |
| Dec 31, 2024 | 1.48B | 13.92% |
| Dec 29, 2023 | 1.30B | 8.31% |
| Dec 30, 2022 | 1.20B | -4.26% |
| Dec 30, 2021 | 1.26B | 76.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 188.45B |
| PharmaEssentia | 175.63B |
| Bora Pharmaceuticals Co., LTD. | 84.20B |
| Lotus Pharmaceutical | 55.88B |
| Oneness Biotech | 29.13B |
| Polaris Group | 29.05B |
| Center Laboratories | 26.46B |
| Lumosa Therapeutics | 23.13B |